EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today announced the closing of its previously announced firm commitment underwritten public offering of 12,500,000 shares of the Company’s common stock at a purchase price of $1.60 per share.
